“One single cancer drug pulled in $25 billion in a year for this drugmaker, proof that the pharma market dwarfs the AI hype everyone obsesses over.”
“Keytruda, that drug that I mentioned that Merck did in 2019, that one drug's top line last year for Merck, $25 billion in revenue. Just that one drug.”
Prices are point-in-time snapshots from the named provider. The verdict compares the return since entry against the band above.